ZINADOX-750 TABLET

Product Description

ZINADOX-750 TABLET (PYRAZINAMIDE 750MG)

ZINADOX-750 Tablet contains Pyrazinamide 750mg, a frontline antitubercular agent used in combination therapy for the treatment of tuberculosis (TB). It plays a crucial role in shortening TB treatment duration by targeting semi-dormant bacilli residing in acidic environments.

Key Benefits:

• Potent bactericidal activity against Mycobacterium tuberculosis

• Essential component of first-line TB treatment regimens

• Helps prevent development of drug resistance when used in combination

• WHO-recommended active pharmaceutical ingredient (API)

Usage/Application:

ZINADOX-750 is prescribed as part of Directly Observed Treatment Short-course (DOTS) and is widely used in government and private TB eradication programs. It is typically administered under medical supervision during the intensive phase of TB treatment.

Industry Use:

Ideal for hospitals, clinics, government supply contracts, pharmaceutical wholesalers, and global health NGOs. Available for bulk procurement and third-party manufacturing with quality compliance.